Ariad Patents Technology for Regulating Gene Expression | GenomeWeb

NEW YORK, Feb 13 – Ariad Pharmaceuticals received a patent for a method to control gene expression in humans and other animals, the company said Tuesday.

The technology uses small molecules to regulate the extent of gene activation. It is part of Ariad’s Argent gene regulation system, a gene regulation technology designed for high throughput analysis of in vitro and in vivo gene function, and " dose-dependent control” of gene and cell therapy products, Ariad said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.